Researchers in Australia find that JAK inhibitors could halt tumor growth in most bowel cancers.
A new method to silence a mutated gene that drives ALS shows promise for cancer research.
Targeting parallel pathways can potentially create better cancer therapies.
An antibody in clinical trials for blood cancer is shown to target cells critical to growth of solid tumors.
Meet our scientists